Heat Biologics, Inc. Made Headway
Mon 02 Mar 20 at 05:30 PM
Heat Biologics, Inc. (HTBX:NASDAQ) shot up at $0.8, representing a gain of 142.4%. On Fri 28 Feb 20, HTBX:NASDAQ hit a New 2-Week High of $0.33. The stock appeared on our News Catalysts scanner on Fri 28 Feb 20 at 05:35 PM in the 'INVESTOR UPDATE' category. From Fri 07 Feb 20, the stock recorded 28.57% Up Days and 20.00% Green Days
About Heat Biologics, Inc. (HTBX:NASDAQ)
Heat Biologics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of novel allogeneic, 'off-the-shelf' cellular therapeutic vaccines to combat various cancers and infectious diseases.
Top 10 Gainers:
- Heat Biologics, Inc. (HTBX:NASDAQ), 142.42%
- Novan, Inc. (NOVN:NASDAQ), 112.51%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 100%
- BioPharmX Corporation (BPMX:NYSEMKT), 78.38%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 69.65%
- Daxor Corporation (DXR:NYSEMKT), 65.7%
- Forty Seven, Inc. (FTSV:NASDAQ), 61.91%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 55.83%
- NuCana plc (NCNA:NASDAQ), 45.74%
- InflaRx N.V. (IFRX:NASDAQ), 43.4%